Obligacje TEV
Poniżej znajduje się lista obligacji korporacyjnych TEVA PHARMACEUT. SP.ADR. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
|---|---|---|---|---|---|---|---|---|---|
| TTEVA5034099Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 8,41% | 500 K | 99,73% | 7,13% | 2025-01-31 | 425,26 M USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTFACTEVA P.FI.NL III 16/46 | 7,60% | 0 | 71,25% | 4,10% | 2046-10-01 | 2 B USD | 1 000,00 USD | 2 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608603Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 6,96% | 1 M | 99,25% | 6,75% | 2028-03-01 | 255 K USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4914602Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 6,44% | 0 | 101,25% | 7,13% | 2025-01-31 | 1,25 M USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88163VAD1TEVA PHARM.FIN. 2036 | 6,17% | 0 | 99,89% | 6,15% | 2036-02-01 | 789,43 M USD | 1 000,00 USD | 2 000,00 USD | Teva Pharmaceutical Finance Co. LLC |
| TTFABTEVA P.FI.NL III 16/26 | 5,94% | 0 | 95,33% | 3,15% | 2026-10-01 | 3,38 B USD | 1 000,00 USD | 2 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5295244Teva Pharmaceutical Finance Netherlands III BV 4.75% 09-MAY-2027 | 5,85% | 1,91 M | 97,63% | 4,75% | 2027-05-09 | 1 B USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608604Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 5,85% | 300 K | 102,47% | 6,75% | 2028-03-01 | 1,25 B USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5295245Teva Pharmaceutical Finance Netherlands III BV 5.125% 09-MAY-2029 | 5,83% | 2,23 M | 97,50% | 5,13% | 2029-05-09 | 1 B USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5549923Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029 | 5,71% | 585 K | 108,19% | 7,88% | 2029-09-15 | 600 M USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5549924Teva Pharmaceutical Finance Netherlands III BV 8.125% 15-SEP-2031 | 5,68% | 5,42 M | 112,02% | 8,13% | 2031-09-15 | 500 M USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| XXS219821395TEVA PHARM FINANCE NL II 6% GTD SNR NTS 31/01/2025 EUR100000 | 5,30% | 0 | 100,14% | 6,00% | 2025-01-31 | 410,61 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS181372460TEVA PH.F.NL.II 18/25 | 4,50% | 0 | 100,00% | 4,50% | 2025-03-01 | 494,35 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660717TEV.P.F.N.II 21/30 | 4,20% | 0 | 100,80% | 4,38% | 2030-05-09 | 1,5 B EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280419TEV.P.F.N.II 23/31 | 4,17% | 0 | 119,64% | 7,88% | 2031-09-15 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280443TEV.P.F.N.II 23/29 | 4,05% | 0 | 113,41% | 7,38% | 2029-09-15 | 800 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS121104407TEVA PH.F.NL.II 15/27 | 3,98% | 0 | 95,46% | 1,88% | 2027-03-31 | 700 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660709TEV.P.F.N.II 21/27 | 3,92% | 0 | 99,61% | 3,75% | 2027-05-09 | 1,1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS143974936TEVA PH.F.NL.II 16/28 | 3,91% | 0 | 92,26% | 1,63% | 2028-10-15 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| CCH33382750TEVA PH.FI.NL IV 16-25 | 2,57% | 0 | 98,95% | 1,00% | 2025-07-28 | 350 M CHF | 5 000,00 CHF | 5 000,00 CHF | Teva Pharmaceutical Finance Netherlands IV BV |
| TTEVA.GJTeva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026 | 2,17% | 430 K | 97,00% | 0,25% | 2026-02-01 | 22,88 M USD | 1 000,00 USD | 1 000,00 USD | Teva Pharmaceutical Finance Co. LLC |
| TTEVA3666246IVAX LLC 1.875% 15-DEC-2024 | — | — | — | 1,88% | 2024-12-15 | 333 M USD | 1 000,00 USD | 1 000,00 USD | IVAX LLC |